Science and Technology Innovation Program
This July 2011 issue of Synthetic Biology 2.0 looks at the work of the United States Presidential Bioethics Commission, the dominant discourse in the synthetic biology debate, vaccines as the first commercial applicaiton of synthetic biology, do-it-yourself biology, biosecurity, and biofiction where science and arts meet.
According to Andrew Maynard, chief science advisor for the Wilson Center's Project on Emerging Nanotechnologies, a project created in partnership with The Pew Charitable Trusts, the release of Approaches to Safe Nanotechnology: An Information Exchange with NIOSH and Strategic Plan for NIOSH Nanotechnology Research: Filling the Knowledge Gaps is a small but important step forward by the U.S. government to address the possible health implications of nanotechnology.
Scientists talk about the convergence of nanotechnology, biotechnology, information technology and cognitive science in this collection of exclusive interviews produced by the Science & Technology Innovation Program in conjunction with the National Science Foundation.
The Intel Corporation congratulates the Woodrow Wilson Center on the publication of their new report, "Nanotechnology: A Research Strategy for Addressing Risk." Intel is a leader in the field of nano-electronics and has long been a leader in environmental health and safety (EHS).
The CommonsLab is proud to announce the release of a report by Ed Robson evaluating liability issues in social media and crowdsourcing.
David Rejeski Testifies in front of the Senate Commerce Committee.
Products incorporating nanotechnology have become a global, multi-billion dollar industry yet much of the public knows little about nano's potential impact on the environment, human health, and privacy. A three-part tv series, "Nanotechnology: The Power of Small," airing in April, will explore these issues.